Hematological Oncology

Published by: Wiley Blackwell  

People

  1. Park
    Park
  2. Sadelain
    Sadelain
  3. Palomba
    Palomba
  4. Wang
    Wang
  5. Bernal
    Bernal
  6. Giralt
    Giralt
  7. Curran
    Curran
  8. Dahi
    Dahi
  9. Hall
    Hall
  10. Imber
    Imber

Groups

  1. Adult Leukemia (4)
  2. Center for Hematologic Malignancies (4)
  3. Department of Medicine (4)
  4. GSK Faculty (4)
  5. Hematologic Malignancies Research (4)
  6. Hematologic Malignancies, Division of (4)
  7. Lymphoma (4)
  8. Molecular Pharmacology and Chemistry Program Faculty (4)
  9. Sloan Kettering Institute Faculty (4)
  10. Bone Marrow Transplant (2)
Search Within
  1. "Michel Sadelain"
Formats
  1. Meeting Abstract (4)
Groups
  1. Adult Leukemia (4)
  2. Center for Hematologic Malignancies (4)
  3. Department of Medicine (4)
  4. GSK Faculty (4)
  5. Hematologic Malignancies Research (4)
  6. Hematologic Malignancies, Division of (4)

More Groups

People
  1. Jae Park (4)
  2. Michel Sadelain (4)
  3. Brigitte Senechal (3)
  4. Isabelle Riviere (3)
  5. Maria Palomba (3)
  6. Xiuyan Wang (3)

More People

Years
  1. 2023 (1)
  2. 2019 (2)
  3. 2017 (1)
Publishers
  1. Wiley Blackwell (4)

Results (4)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase I study of CD19‐targeted 19(T2)28z1xx CAR T cells in adult patients with relapsed or refractory diffuse large B‐cell lymphoma
    Meeting Abstract

    Palomba, M. L.; Riviere, I.; Sikder, D. S.; Senechal, B.; Wang, X.; Cathcart, E. R.; Liotta, K.; Li, J.; Sellner, L.; Sadelain, M.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • MSKCC early experience using radiotherapy as a bridging strategy for relapsed diffuse large B cell lymphoma before CD19 CAR T therapy
    Meeting Abstract

    Imber, B. S.; Palomba, M. L.; DeSelm, C.; Batlevi, C.; Dahi, P. B.; Giralt, S.; Noy, A. M.; Park, J. H.; Sauter, C. S.; Scordo, M.; more...
    Hematological Oncology (2019)

    Fulltext@MSK | Save
  • Phase I clinical trial of CD19‐targeted 19‐28z/4‐1BBL "armored" CAR T cells in patients with relapsed or refractory NHL and CLL including Richter transformation
    Meeting Abstract

    Batlevi, C. L.; Palomba, M. L.; Park, J.; Mead, E.; Santomasso, B.; Riviere, I.; Wang, X.; Senechal, B.; Furman, R.; Yang, J.; more...
    Hematological Oncology (2019)

    Fulltext@MSK | Save
  • A Phase I trial of 19-28z CAR-T cells post-high dose therapy and autologous transplantation (HDT-ASCT) for relapsed and refractory (R/R) B-cell non-Hodgkin lymphoma (B-NHL)
    Meeting Abstract

    Sauter, C.; Riviere, I.; Senechal, B.; Ni, A.; Bernal, Y.; Wang, X.; Purdon, T.; Hall, M.; Moskowitz, C.; Giralt, S.; more...
    Hematological Oncology (2017)

    Fulltext@MSK | Save

    • Hematological Oncology – authorized name for:

    Name ISSN / ISBN Publisher
    Hematological Oncology 02780232 John Wiley & Sons
    Hematological Oncology 0278-0232 John Wiley & Sons
    Hematological Oncology 0278-0232 Wiley Blackwell
    Hematological Oncology 02780232 John Wiley & Sons
    Hematological Oncology 02780232 Unknown
    Hematological Oncology 0278-0232 John Wiley & Sons
    Hematological Oncology 02780232 John Wiley & Sons
    Hematological Oncology 0278-0232 Unknown
    Hematological Oncology 0278-0232 John Wiley & Sons
    Hematological Oncology 0278-0232 Wiley Blackwell